Spartan Bioscience2934 Baseline Rd #500 Nepean, ON, Canada K2H 1B2Latest from Spartan BioscienceBlood ClotsGenetic testing cut adverse events in heart patientsBy Melissa BuschPatients often will be prescribed the blood thinner clopidogrel to prevent blood clots after undergoing percutaneous coronary intervention procedures, which can irritate blood vessels and cause clots.August 26, 2020Companion DiagnosticsCompanion diagnostics survive COVID-19 with small nickBy Bruce CarlsonKalorama, which is a sister company of LabPulse.com, found continued revenue growth and only a small impact on the market, due to the critical importance of cancer therapies these tests are paired with, in its new report "Companion Diagnostics in the COVID-19 Era."July 5, 2020510(k)Spartan aims to deploy rapid, portable testing for COVID-19By LabPulse.com staff writersThe Spartan Cube is a sample-to-result platform designed for in-field diagnostic testing. It has already received clearance from the U.S. Food and Drug Administration and the European CE Mark, the company noted.March 18, 2020Companion DiagnosticsGenotyping spares bleeding with cardiovascular drugsBy Emily HayesThe randomized study showed that the P2Y12 inhibitor clopidogrel (Plavix) was as effective as newer drugs in the class -- ticagrelor (Brilinta) or prasugrel (Effient) -- for preventing thrombotic events in patients undergoing PCI with stent implantation, but with significantly less bleeding. In addition to the presentation at the meeting, results were reported by Dr. Jurriën ten Berg, PhD, of St. Antonius Hospital in Nieuwegein, the Netherlands, and colleagues in the New England Journal of Medicine online September 3.September 4, 2019
